Adverse health outcomes for prostate cancer patients treated with radiotherapy combined with androgen-deprivation therapy: A population-based, controlled study, from Norway
Three years post-RT+ADT, PCa patients describe clinically important lower EPIC-26 bowel and sexual DSS compared to controls. Sexual domain levels decreased with increasing ADT duration, particularly in patients < 75 years. Our observations indicate worse AHOs than previously reported and should be considered during pre-treatment counselling of PCa patients.
Authors
- Ylva Maria Gjelsvik (ORCID: https://orcid.org/0000-0001-5027-9482)
- Anne Holck Storås (ORCID: https://orcid.org/0000-0002-9376-9163)
- Kirsti Aas (ORCID: https://orcid.org/0000-0002-2125-227X)
- Sophie D. Fosså (ORCID: https://orcid.org/0000-0002-3729-2217)
- Tom Børge Johannesen (ORCID: https://orcid.org/0000-0001-8633-1633)
- Tor Åge Myklebust (ORCID: https://orcid.org/0000-0003-4645-1635)
- Mona Nilsson (ORCID: https://orcid.org/0000-0002-0145-4472)
Institutions
- Oslo University Hospital (NO)
- Norwegian Institute of Public Health (NO)
- University of Oslo (NO)
- Akershus University Hospital (NO)
- Ålesund Hospital (NO)
- Cancer Registry of Norway (NO)
Publication Details
- Journal
- Acta Oncologica
- Published
- 2025-08-25
- DOI
- https://doi.org/10.2340/1651-226x.2025.42825
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Movember Foundation